"expecting an imminent response from the US FDA"
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.08%
!
46.0¢

"expecting an imminent response from the US FDA"
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
46.0¢ |
Change
-0.005(1.08%) |
Mkt cap ! $182.8M |
Open | High | Low | Value | Volume |
47.0¢ | 47.5¢ | 43.0¢ | $193.5K | 424.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8791 | 45.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.0¢ | 4986 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8791 | 0.455 |
7 | 140173 | 0.450 |
1 | 8166 | 0.445 |
4 | 27668 | 0.440 |
5 | 23511 | 0.435 |
Price($) | Vol. | No. |
---|---|---|
0.460 | 4986 | 1 |
0.465 | 78000 | 1 |
0.470 | 121674 | 4 |
0.475 | 45515 | 5 |
0.480 | 107895 | 5 |
Last trade - 11.20am 07/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
AGC
AUSTRALIAN GOLD AND COPPER LTD
Glen Diemar, MD
Glen Diemar
MD
Previous Video
Next Video
SPONSORED BY The Market Online